Target intelligence / Profile preview

Olfactory receptor family 2 subfamily A member 2 (OR2A2)

Target
OR2A2
Molecular classification
G protein-coupled receptor, Receptor
01

Overview

Olfactory receptor family 2 subfamily A member 2 (OR2A2) is a member of the large olfactory receptor gene family in humans. OR2A2 encodes a G protein-coupled receptor (GPCR) with seven transmembrane domains, primarily expressed in the olfactory epithelium, where it detects odorant molecules and initiates a neural response for the perception of smell[1][2][3]. Olfactory receptors, including OR2A2, share structural features with other GPCRs, including conserved motifs across their seven transmembrane helices. These receptors generally bind a variety of odorants, which can trigger conformational changes resulting in G protein activation and neuronal signaling[2]. While most olfactory receptors, including OR2A2, are not established therapeutic targets and have limited disease association, there is emerging research into possible roles in non-olfactory tissues, although no clear drug interactions or disease biomarker roles are defined for OR2A2[1][2][3].

Other names
Olfactory receptor 2A2OR2A2OR2A17POR2A2POST008Olfactory receptor 2A17Olfactory receptor OR7-11OR7-11olfactory receptor, family 2, subfamily A, member 17 pseudogeneolfactory receptor, family 2, subfamily A, member 2 pseudogene
02

Mechanism of action

Not applicable (no drugs are known to target this receptor; standard function involves activation by odorant molecules, which trigger G protein-coupled signaling in olfactory sensory neurons[1][2][3])

03

Biological functions

Signal transductionSensory perception of smell (olfaction)
04

Disease associations

Other (no established major disease associations; olfactory receptors are primarily involved in sensory function rather than disease, though expression in non-olfactory tissues is under study[1][3])
05

Safety considerations

None established (olfactory receptors are not typically targeted by therapeutics; safety challenges are not described in the literature[1][2][3])
06

Interacting drugs

None known (olfactory receptors are not conventional drug targets; no approved drugs are known to interact with OR2A2 specifically[1][2][3])
07

Biomarkers

None established for patient selection or efficacy monitoring

Beyond the preview

Go deeper on Olfactory receptor family 2 subfamily A member 2 (OR2A2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Olfactory receptor family 2 subfamily A member 2 (OR2A2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call